Picture of Genus logo

GNS Genus News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

REG - Genus - Results of AGM

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251119:nRSS2101Ia&default-theme=true

RNS Number : 2101I  Genus PLC  19 November 2025

Genus plc (the 'Company') - 2025 AGM Poll Results

 

The Company announces that at its AGM held on Wednesday, 19 November 2025,
all resolutions set out in the Notice of AGM were passed on a poll.

 

Resolutions 1 to 16 were passed as Ordinary Resolutions and Resolutions 17
to 20 were passed as Special Resolutions. The following table sets out the
votes cast on each resolution:
 
 
 

 

 Resolutions                                                                     In Favour   %       Against    %      Abstentions  Total no. of shares in respect of which proxies were validly made

                                                                                 Votes               Votes             Votes
 1.     To receive the accounts and reports of the Directors and auditor         46,614,670  100.00  223        0.00   212,706      46,614,893
 for the year ended 30 June 2025.
 2.     To approve the Directors' Remuneration Report (other than the part       46,213,689  99.07   434,225    0.93   179,685      46,647,914
 containing the Directors' Remuneration Policy) for the year ended 30 June
 2025, as set out on pages 80 to 119 of the Company's Annual Report 2025.
 3.     To approve the Directors' Remuneration Policy as set out on pages        46,162,544  98.71   602,266    1.29   62,789       46,764,810
 94 to 102 of the Company's Annual Report 2025.
 4.     To approve the rules of the Genus 2025 Long Term Incentive Plan.         45,424,681  97.14   1,338,673  2.86   64,245       46,763,354
 5.     To approve the rules of the Genus 2025 Deferred Bonus Plan.              46,579,546  99.48   241,156    0.52   6,897        46,820,702
 6.     That the restricted share awards granted to Andrew Russell in            46,488,683  99.30   327,881    0.70   11,035       46,816,564
 compensation for the forfeiture of awards granted to him by his previous
 employer and to other senior executives as announced by the Company on 11
 September 2025 be capable of being settled through the issuance of new shares
 or transfer of treasury shares.
 7.     To declare a final dividend of 21.7 pence per Ordinary Share.            46,824,165  100.00  963        0.00   2,471        46,825,128
 8.     To elect Andrew Russell as a Director of the Company.                    46,356,916  99.01   465,436    0.99   5,247        46,822,352
 9.     To re-elect Jorgen Kokke as a Director of the Company.                   46,185,235  99.00   465,044    1.00   177,320      46,650,279
 10.  To re-elect Iain Ferguson CBE as a Director of the Company.                40,429,198  87.10   5,989,560  12.90  408,841      46,418,758
 11.  To re-elect Ralph Heuser as a Director of the Company.                     46,125,505  98.51   698,168    1.49   3,926        46,823,673
 12.  To re-elect Lysanne Gray as a Director of the Company.                     45,885,489  97.99   938,943    2.01   3,167        46,824,432
 13.  To re-elect Lesley Knox as a Director of the Company.                      46,237,046  98.75   586,177    1.25   4,376        46,823,223
 14.  To re-appoint PricewaterhouseCoopers LLP as auditor of the Company.        46,818,022  99.99   6,260      0.01   3,317        46,824,282
 15.  To authorise the Audit & Risk Committee of the Board to determine          46,821,441  100.00  2,046      0.00   4,112        46,823,487
 the remuneration of the auditor.
 16.  To empower the Directors with limited authority to allot Ordinary          44,745,308  95.57   2,072,984  4.43   9,307        46,818,292
 Shares.
 17.  To empower the Directors with limited authority to allot equity            46,464,572  99.95   23,240     0.05   339,787      46,487,812
 securities for cash without first offering them to existing shareholders.
 18.  To empower the Directors with limited authority to allot additional        46,466,003  99.95   22,793     0.05   338,803      46,488,796
 equity securities for cash without first offering them to existing
 shareholders provided that this power be used only in connection with an
 acquisition or other capital investment.
 19.  To empower the Directors with limited authority to make one or more        46,787,787  99.95   21,767     0.05   18,045       46,809,554
 market purchases of any Ordinary Shares.
 20.  To allow a General Meeting other than an Annual General Meeting to be      46,019,156  98.29   802,625    1.71   5,818        46,821,781
 called on not less than 14 clear days' notice.

 

A copy of the special business resolutions will be submitted to the National
Storage Mechanism and will soon be available to view at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

As at the close of business on 17 November 2025, the total number of ordinary
shares of £0.10 each eligible to be voted at the AGM was 66,537,765.

Therefore, the total voting rights in the Company as at that time were
66,537,765. The proportion of the Company's issued share capital represented
by the votes validly cast was 70.37%.

Equiniti acted as scrutineer of the poll on all resolutions.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGUKAURVRUAAAA



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Genus

See all news